Veru

Veru Working Capital

The Working Capital of Veru (VERU) as of Oct 17, 2026 is 6.47 M USD. In the previous year, Working Capital was 15.32 M USD — a change of -57.80% (lower).

Working Capital

6.47 MUSD

YoY

-57.80%

Last updated:

Working Capital of Veru is 2025 6.47 M USD. Working Capital of Veru was 2024 15.32 M USD. It decreases by -57.80% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Veru Stock analysis

What does Veru do? Veru Inc., headquartered in Miami, Florida, operates in the Consumer Staples sector within the Consumer products industry. The company develops and markets FC2, a female condom for protection against unintended pregnancy and STIs. With 20 employees, Veru focuses on oncology biopharmaceuticals, including prostate cancer treatments like VERU-111 and VERU-100, alongside research and development activities. Listed on the stock market since 1990, the company manages both commercial and R&D segments. Veru is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Veru stock

Working Capital of Veru is 6.47 M USD in 2025.

Working Capital of Veru changed from 15.32 M USD to 6.47 M USD, representing a -57.80% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Working Capital Veru since 2006 – with annual values, charts, and detailed analysis.

Working capital is the difference between current assets and current liabilities. Positive working capital indicates a company can meet its short-term obligations.

Working Capital's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Working Capital's Veru historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Veru

All Key Metrics — Veru